First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 805.7 INR -1.14% Market Closed
Updated: Apr 29, 2024

Glenmark Life Sciences Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Glenmark Life Sciences Ltd
Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Revenue
₹21.6B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
₹272.1B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
₹253.5B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
₹474.4B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
12%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Revenue
₹186.8B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
11%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
₹87.5B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Revenue?
Revenue
21.6B INR

Based on the financial report for Mar 31, 2023, Glenmark Life Sciences Ltd's Revenue amounts to 21.6B INR.

What is Glenmark Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 3Y
12%

Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Glenmark Life Sciences Ltd have been 12% over the past three years .